The mission of iMed.UL is to foster fundamental research at the interface between biology and chemistry aimed at (i) understanding the genetic and molecular basis of human diseases and (ii) improving the development of novel therapeutic agents and medicines, using a translational research approach. iMed.UL was created to fill a gap at the national level in terms of interdisciplinary teams capable of developing basic-to-applied research based on the drug discovery and development (DDD) paradigm. Some iMed.UL core groups have links to other researchers in pharmaceutical companies, thus allowing knowledge and skill transfer on drug development process. Another important mission of iMed.UL is to provide advanced training in pharmaceutical and related sciences at the post-graduate level.
Looking for a particular iMed.UL employee's phone or email?
The iMed.UL annual revenue was $2.9 billion in 2026.
10 people are employed at iMed.UL.
iMed.UL is based in Evora, Evora.
The NAICS codes for iMed.UL are [611310, 6113, 611, 61, 541, 54, 61131].